Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer.

Vrba L, Muñoz-Rodríguez JL, Stampfer MR, Futscher BW.

PLoS One. 2013;8(1):e54398. doi: 10.1371/journal.pone.0054398. Epub 2013 Jan 16.

2.

Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer.

Wee EJ, Peters K, Nair SS, Hulf T, Stein S, Wagner S, Bailey P, Lee SY, Qu WJ, Brewster B, French JD, Dobrovic A, Francis GD, Clark SJ, Brown MA.

Oncogene. 2012 Sep 20;31(38):4182-95. doi: 10.1038/onc.2011.584. Epub 2012 Jan 9.

3.

DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.

Pronina IV, Loginov VI, Burdennyy AM, Fridman MV, Senchenko VN, Kazubskaya TP, Kushlinskii NE, Dmitriev AA, Braga EA.

Gene. 2017 Mar 10;604:1-8. doi: 10.1016/j.gene.2016.12.018. Epub 2016 Dec 18.

PMID:
27998789
4.

Aberrant methylation of miR-34b is associated with long-term shiftwork: a potential mechanism for increased breast cancer susceptibility.

Liu R, Jacobs DI, Hansen J, Fu A, Stevens RG, Zhu Y.

Cancer Causes Control. 2015 Feb;26(2):171-178. doi: 10.1007/s10552-014-0494-z. Epub 2014 Nov 15.

PMID:
25398683
5.

Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.

Menschikowski M, Hagelgans A, Nacke B, Jandeck C, Sukocheva O, Siegert G.

BMC Cancer. 2015 Dec 16;15:971. doi: 10.1186/s12885-015-1937-y.

6.

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.

Tanaka N, Toyooka S, Soh J, Kubo T, Yamamoto H, Maki Y, Muraoka T, Shien K, Furukawa M, Ueno T, Asano H, Tsukuda K, Aoe K, Miyoshi S.

Lung Cancer. 2012 Apr;76(1):32-8. doi: 10.1016/j.lungcan.2011.10.002. Epub 2011 Nov 1.

7.

Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers.

Shi F, Chen X, Fu A, Hansen J, Stevens R, Tjonneland A, Vogel UB, Zheng T, Zhu Y.

Environ Mol Mutagen. 2013 Jul;54(6):406-13. doi: 10.1002/em.21790. Epub 2013 Jun 27.

PMID:
23813567
8.

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.

Lehmann U, Hasemeier B, Christgen M, Müller M, Römermann D, Länger F, Kreipe H.

J Pathol. 2008 Jan;214(1):17-24.

PMID:
17948228
9.

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T.

Cancer Res. 2008 Jun 1;68(11):4123-32. doi: 10.1158/0008-5472.CAN-08-0325.

10.

Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.

Mazar J, Khaitan D, DeBlasio D, Zhong C, Govindarajan SS, Kopanathi S, Zhang S, Ray A, Perera RJ.

PLoS One. 2011;6(9):e24922. doi: 10.1371/journal.pone.0024922. Epub 2011 Sep 19.

11.

Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.

Poli E, Zhang J, Nwachukwu C, Zheng Y, Adedokun B, Olopade OI, Han YJ.

PLoS One. 2015 Nov 5;10(11):e0142224. doi: 10.1371/journal.pone.0142224. eCollection 2015.

12.

Epididymal Region-Specific miRNA Expression and DNA Methylation and Their Roles in Controlling Gene Expression in Rats.

Chu C, Zheng G, Hu S, Zhang J, Xie S, Ma W, Ni M, Tang C, Zhou L, Zhou Y, Liu M, Li Y, Zhang Y.

PLoS One. 2015 Apr 22;10(4):e0124450. doi: 10.1371/journal.pone.0124450. eCollection 2015.

13.

Disruption of CTCF at the miR-125b1 locus in gynecological cancers.

Soto-Reyes E, González-Barrios R, Cisneros-Soberanis F, Herrera-Goepfert R, Pérez V, Cantú D, Prada D, Castro C, Recillas-Targa F, Herrera LA.

BMC Cancer. 2012 Jan 25;12:40. doi: 10.1186/1471-2407-12-40.

14.

MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.

Aydoğdu E, Katchy A, Tsouko E, Lin CY, Haldosén LA, Helguero L, Williams C.

Carcinogenesis. 2012 Aug;33(8):1502-11. doi: 10.1093/carcin/bgs161. Epub 2012 May 4.

PMID:
22562546
15.

Genome-wide analysis of DNA methylation and expression of microRNAs in breast cancer cells.

Morita S, Takahashi RU, Yamashita R, Toyoda A, Horii T, Kimura M, Fujiyama A, Nakai K, Tajima S, Matoba R, Ochiya T, Hatada I.

Int J Mol Sci. 2012;13(7):8259-72. doi: 10.3390/ijms13078259. Epub 2012 Jul 3.

16.

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.

Tahiri A, Leivonen SK, Lüders T, Steinfeld I, Ragle Aure M, Geisler J, Mäkelä R, Nord S, Riis ML, Yakhini Z, Kleivi Sahlberg K, Børresen-Dale AL, Perälä M, Bukholm IR, Kristensen VN.

Carcinogenesis. 2014 Jan;35(1):76-85. doi: 10.1093/carcin/bgt333. Epub 2013 Oct 8.

PMID:
24104550
17.

miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.

Endo Y, Toyama T, Takahashi S, Yoshimoto N, Iwasa M, Asano T, Fujii Y, Yamashita H.

Endocr Relat Cancer. 2013 Feb 18;20(1):91-102. doi: 10.1530/ERC-12-0207. Print 2013 Feb.

18.

Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.

Sandhu R, Rivenbark AG, Mackler RM, Livasy CA, Coleman WB.

Int J Oncol. 2014 Feb;44(2):563-72. doi: 10.3892/ijo.2013.2197. Epub 2013 Nov 29.

19.

Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.

Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.

Clin Cancer Res. 2003 Dec 15;9(17):6389-94.

20.

DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family.

Wong KY, Yu L, Chim CS.

Epigenomics. 2011 Feb;3(1):83-92. doi: 10.2217/epi.10.74. Review.

PMID:
22126155

Supplemental Content

Support Center